Cargando…
Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium
The Ebola crisis occurred in West-Africa highlights the urgency for its clinical treatments. Currently, no Food and Drug Administration (FDA)-approved therapeutics are available. Several FDA-approved drugs, including selective estrogen receptor modulators (SERMs), possess selective anti-Ebola activi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259750/ https://www.ncbi.nlm.nih.gov/pubmed/28117364 http://dx.doi.org/10.1038/srep41226 |